Line Broch

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

Cecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch et al. · Frontiers in Neurology · 2021 · 104 citations · Full text

Medicine, Neurology, Pharmacotherapy +9

High prevalence of fatigue in contemporary patients with multiple sclerosis

Line Broch, Cecilia Smith Simonsen, Heidi Øyen Flemmen et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2021 · 69 citations · Full text

Medicine, Internal Medicine, Neurology +16

Caries experience as predictor for caries incidence

Jan Magne Birkeland, Line Broch, L. Jorkjend · Community Dentistry And Oral Epidemiology · 1976 · 62 citations

Dentistry, Pediatric Dentistry, Preventive Dentistry +17

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

Christopher Storm-Larsen, K-M Myhr, Elisabeth Farbu et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2019 · 49 citations · Full text

Life Sciences, Microbiology, Pharmacology +16

The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression

Cecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch et al. · Journal of Neurology · 2020 · 39 citations · Full text

Medicine, Neurology, Disability Management +16